These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7856279)

  • 1. [Modification of re-stenosis with drugs].
    Scheffold T; Müller-Bardorff M; Greten T; von Hodenberg E; Katus HA
    Z Kardiol; 1994; 83 Suppl 4():43-9. PubMed ID: 7856279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive drug therapy following coronary bypass surgery or PTCA].
    Lechleitner P; Genser N; Dienstl F
    Wien Med Wochenschr; 1990 Jun; 140(10-11):277-8, 281. PubMed ID: 2368420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stable ischemic coronary disease--medical therapy or PCI?].
    Mickley H; Egstrup K
    Ugeskr Laeger; 2007 Jun; 169(23):2227. PubMed ID: 17607849
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 7. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
    Mukherjee D; Mahaffey KW; Moliterno DJ; Harrington RA; Yadav JS; Pieper KS; Gallup D; Dyke C; Roe MT; Berdan L; Lauer MS; Mänttäri M; White HD; Califf RM; Topol EJ
    Am Heart J; 2002 Dec; 144(6):995-1002. PubMed ID: 12486423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
    Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
    Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New strategies in the treatment of restenosis].
    von Hodenberg E; Tost B; Scheffold T
    Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
    Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
    Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.
    Lee DS; Bhatt DL; Moliterno DJ; Peacock WF; Ellis SG; Topol EJ
    J Invasive Cardiol; 2004 Feb; 16(2):46-51. PubMed ID: 14760188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of locally delivered conventional drug therapies.
    Camenzind E; Kutryk MJ; Serruys PW
    Semin Interv Cardiol; 1996 Mar; 1(1):67-76. PubMed ID: 9552496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation.
    Kereiakes DJ
    Circulation; 2003 Oct; 108(16 Suppl 1):III22-7. PubMed ID: 14605016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current approach in antithrombotic treatment during coronary interventions: specific thrombocyte aggregation inhibitors and direct thrombin antagonists in high-risk patients].
    Meyer BJ
    Schweiz Med Wochenschr; 1996 Nov; 126(46):1961-9. PubMed ID: 8984604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.